Acrónimos

S-LiTE · Combined Effects of GLP-1 Analogue and Exercise on Maintenance of Weight Loss and Health After Very-low Calorie Diet S/V · Sacabutril/Valsartan S3 · Segmento-3 SAE · sesiones de apoyo y educación SAHOS · Síndrome de Apnea hipopnea Obstructiva del Suaño SAI · Sistemas de administración Automatizada de Insulina SAID · Diabetes Autoinmunidad Severa SARC-F · Strength, Assistance Walking, Rise from a Chair, Climb Stairs, and Falls SARS-CoV-2 · Síndrome Respiratorio Agudo Severo por CoronaVirus 2 SAVOR-TIMI · Saxagliptin Assessment of Vascular Outcomes Recorded in Patients With Diabetes Mellitus–Thrombolysis in Myocardial Infarction  SCA · Sudden Cardiac Arrest SCALE · Satiety and Clinical Adiposity – Liraglutide Evidence in individuals with and without diabetes SCD · Standars of Care in Diabetes SCFAs · Short-chain fatty acid SCI-Diabetes · Scottish Care Information-Diabetes SCORE · Systematic Coronary Risk Evaluation SCORED · Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk SCPI · Índice de habilidades, confianza y preparación SD · Sarcopenia Diabética SDRN-NDS · Scottish Diabetes Research Network–National Diabetes Study  SDRN-NDS · Scottish Diabetes Research Network–National Diabetes Study  SEARCH · SEARCH for Diabetes in Youth SECURE · SEcondary prevention of Cardiovasc UlaR disease in the Elderl SELECT · Semaglutide effects on heart disease and stroke in patients with over weigh to obesity SELECT-CVOT · Select-Seguridad Cardiovascular SEMA · Semaglutide SF-36 · Short Form 36  SGA · SMALL for Gestacional Age SHBG · Sex Hormone Binding Globulin sHR · resumen índice de riesgo SIDD · Diabetes con deficiencia severa de insulina SIDIACO-RETRO · Sitagliptin Treatment in Diabetic COVID-19 Positive Patients SIDIAP · Sistema d’Informació per al Desenvolupament de la Investigació en Atenció Primària SIGN · Scottish Intercollegiate Guidelines Network SIND · Severe Inflammatory, Non-lymphocyte Dominant SIR · Standardized Incidence Ratio SIRD · Diabetes con resistencia grave a la Insulina (severe insulin resistance diabetes) SLD · Steatotic Liver Disease (fermedad hepática esteatósica) SLD · Steatotic Liver Disease (enfermedad hepática esteatósica) SLIMM-T2D · Surgery or Lifestyle With Intensive Medical Management in the Treatment of Type 2 Diabetes SM · SÍNDROME METABÓLICO SMBG · Self-monitoring of blood glucose (Sistema de Monitorización de Glucosa Basal) SMBG · Self-monitoring of blood glucose ( Autocontrol de la glucemia) SMC · Standars of Medical Care SMCG · Sistema de Monitorización Continua de Glucosa SMCG-int · SMCG de escaneo intermitente SMCG-tr · SMCG en tiempo real SMS · Servicio de Mensajes Simples SNPs · Single Nucleotide Polymorphisms (nucleótidos de un solo polimorfismos) SNS · Sistema Nacional de Salud SNUS · Swedish smokeless tobacco SODAS · Study of Drinks with Artificial Sweeteners SOG · Prueba de Sobrecarga o tolerancia oral a la glucosa. SOLOIST-WHF · Sotagliflozin on Cardiovascular Events in Patients With Diabetes and recient Heart Failure SOPQ · Síndrome de Ovario Poliquistico SOS · Swedish Obese Subjects (Sujetos Obesos Suecos) SOSR · Scandinavian Obesity Surgery Registry SOTA · Sotagliflocina SOUL · Semaglutide cardiOvascular oUtcomes triaL SOURMONT · Study of Tirzepatide in participants with obesity or Overweigth SOURMOUNT · Study of Tirzepatide in Participants With Obesity or Overweight SPD · Sistema Personalizado de Dosificación SPLENDID · Surgical Procedures and Long-term Effectiveness in Neoplastic Disease Incidence and Death SPLENDOR · Surgical Procedures and Long-term Effectiveness in NASH Disease and Obesity Risk SPPB · Short Physical Performance Battery (Bateria de rendimiento físico corto) SPRINT · Systolic Blood Pressure Intervention Trial SRAS · Síndrome Respiratorio Agudo Severo SRAS-CoV-2 · Síndrome Respiratorio Agudo Severo por CoronaVirus 2 SRDA · Sindrome de Distres Respiratorio Agudo SSDMS · Shanghai Standarized Diabetes Management System SSE · Situación SocioEconómica sST2 · péptido factor de tumorogenicidad soluble de tipo 2 STAMPEDE · Surgical Therapy and Medications Potentially Eradicate Diabetes Efficiently STAREE · Statins for Reducing Events in the Elderly STEER STENO 2 · Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. STEP · Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients STEP 1 · Semaglutide Treatment Effect in People with obesity STEP HFpEF · Semaglutide in Patients with Heart Failure  with Preserved Ejection Fraction and Obesity STITCH · Simplified Treatment Intervention to Control Hypertension STRENGTH · Long-Term Outcomes Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia STRIDE · Semaglutida y capacidad para caminar en personas con enfermedad arterial periférica sintomática y diabetes tipo 2 STROBE · Strengthening of Reporting of Observational Studies in Epidemiology SUGAR-DM-HF · StUdies of empaGliflozin and its cArdiovascular, Renal and metabolic effects in patients with Diabetes Mellitus and Heart Failure SUH · Servicio de Urgencias Hospitalario SUMMIT · Tirzepatide in Participants With Heart Failure With Preserved Ejection Fraction and Obesity SURDIAGENE · Suivi Rénal, DIAbète de type 2 et GENEtique SURMOUNT · Study of Tirzepatide in participants with obesity or Overweigth SURMOUNT-MMO · A Study of Tirzepatide on the Reduction on Morbidity and Mortality in Adults With Obesity SURMOUNT-OSA · Study of Tirzepatide in participants with obesity or Overweigth-Obstructive Sleep Apnea SURPASS · Study of Tirzepatide Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes SURPASS COVT · Study of Tirzepatide Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes SURPASS MRI · SURPASS Magnetic Resonance Imaging SURPASS-3 CGM · SURPASS-3 Continuous Glucose Monitoring SURPASS-SWITCH-2 · Cambio de agonistas del receptor del péptido similar al glucagón-1 a tirzepatida 5 mg: SUSTAIN · Semaglutide in Subjects with Type 2 Diabetes SUSTAIN-6 · Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes SVA · Síndrome Valvular Aórtico SWAN · Study of Women’s Health Across the Nation SYNCHRONIZE-1 · A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight